Thermo Fisher Scientific announces extension of tender offer for Dionex

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation (NASDAQ: DNEX) for $118.50 per share in cash ("the Offer") has been extended and will now expire at 12:00 midnight, New York City time, at the end of Wednesday, February 16, 2011, unless further extended. All other terms and conditions of the Offer remain unchanged.

As of 5:00 p.m., New York City time, on January 13, 2011, approximately 3,466,729 shares of Dionex common stock, representing approximately 19.79% of all outstanding shares, had been tendered into and not withdrawn from the offer.

The transaction is subject to the satisfaction of customary closing conditions, including applicable regulatory approvals. As previously announced on January 10, 2011, the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (as amended) expired, satisfying one of these conditions. The company is in the process of seeking similar clearances under antitrust laws of other jurisdictions, and anticipates completing the acquisition later in the first quarter of 2011.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 18). Thermo Fisher Scientific announces extension of tender offer for Dionex. News-Medical. Retrieved on May 30, 2024 from https://www.news-medical.net/news/20110114/Thermo-Fisher-Scientific-announces-extension-of-tender-offer-for-Dionex.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces extension of tender offer for Dionex". News-Medical. 30 May 2024. <https://www.news-medical.net/news/20110114/Thermo-Fisher-Scientific-announces-extension-of-tender-offer-for-Dionex.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific announces extension of tender offer for Dionex". News-Medical. https://www.news-medical.net/news/20110114/Thermo-Fisher-Scientific-announces-extension-of-tender-offer-for-Dionex.aspx. (accessed May 30, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific announces extension of tender offer for Dionex. News-Medical, viewed 30 May 2024, https://www.news-medical.net/news/20110114/Thermo-Fisher-Scientific-announces-extension-of-tender-offer-for-Dionex.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Thermo Scientific Neoma Multicollector ICP-MS system delivers reliable isotopic data